loader
Please Wait
Applying Filters...

Annual Sales of Alprox reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 793Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Xanax

02 5Xanax/Xanax XR

03 1Xanax/Xanax Xr

PharmaCompass

01

Brand Name : Xanax/Xanax XR

Alprazolam

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Xanax/Xanax XR

arrow
Boulder Peptide 2024
Not Confirmed

Alprazolam

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 198

2018 Revenue in Millions : 223

Growth (%) : -11

blank

02

Brand Name : Xanax

Alprazolam

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Xanax

arrow
Boulder Peptide 2024
Not Confirmed

Alprazolam

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 157

2021 Revenue in Millions : 186

Growth (%) : -16

blank

03

Brand Name : Xanax

Alprazolam

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Xanax

arrow
Boulder Peptide 2024
Not Confirmed

Alprazolam

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 155

2022 Revenue in Millions : 157

Growth (%) : -1

blank

04

Brand Name : Xanax

Alprazolam

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Xanax

arrow
Boulder Peptide 2024
Not Confirmed

Alprazolam

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : -8.70%

2013 Revenue in Millions :

Growth (%) :

blank

05

Brand Name : Xanax/Xanax XR

Alprazolam

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Xanax/Xanax XR

arrow
Boulder Peptide 2024
Not Confirmed

Alprazolam

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 253

2014 Revenue in Millions : 224

Growth (%) : -11%

blank

06

Brand Name : Xanax/Xanax Xr

Alprazolam

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Xanax/Xanax Xr

arrow
Boulder Peptide 2024
Not Confirmed

Alprazolam

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 222

2015 Revenue in Millions : 224

Growth (%) : -1

blank

07

Brand Name : Xanax/Xanax XR

Alprazolam

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Xanax/Xanax XR

arrow
Boulder Peptide 2024
Not Confirmed

Alprazolam

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 225

2016 Revenue in Millions : 223

Growth (%) : 1

blank

08

Brand Name : Xanax/Xanax XR

Alprazolam

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Xanax/Xanax XR

arrow
Boulder Peptide 2024
Not Confirmed

Alprazolam

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 222

2017 Revenue in Millions : 225

Growth (%) : -1%

blank

09

Brand Name : Xanax/Xanax XR

Alprazolam

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Xanax/Xanax XR

Country
arrow
Boulder Peptide 2024
Not Confirmed

Alprazolam

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 149

2019 Revenue in Millions : 147

Growth (%) : 1

blank